Developing and Manufacturing Novel RNAi drug Candidates Using Precision NanoSystems' NxGen™ Platform GAITHERSBURG, MD and VANCOUVER, BC, June 17, 2020 /PRNewswire/…
Super UserJune 20, 2020
Emergent BioSolutions (NYSE:EBS) will invest $75M in its Canton, Massachusetts facility, focused on the development and manufacturing of drug substance…
Super UserJune 20, 2020
Business is booming for Emergent BioSolutions as it has assisted in the country’s push to create COVID-19 treatments and vaccines.…
Super UserJune 20, 2020
Emergent BioSolutions has unveiled plans to strengthen its contract development and manufacturing (CDMO) capabilities by expanding into viral vector and…
Super UserJune 20, 2020
Lockheed Martin Ventures -- the defense company’s technology startup investment arm -- has backed two companies through separate avenues announced…
Super UserJune 20, 2020
BALTIMORE, June 11, 2020 (GLOBE NEWSWIRE) -- Glyscend Therapeutics, a privately held biopharmaceutical company developing novel treatments for type 2…
Super UserJune 15, 2020
The BioHealth Capital Region featured at last week’s Redefining Early Stage Investments Conference (RESI) where speakers from the region discussed…
Super UserJune 15, 2020
ROCKVILLE, Md.--(BUSINESS WIRE)--Creatv Microtech, a privately-held biotechnology company has pioneered a blood test to predict treatment response in patients with…
Super UserJune 15, 2020
Fina Biosolutions recently received a $25,000 Montgomery County SBIR/STTR Phase I matching grant to support its NIH SBIR grant focused…
Super UserJune 15, 2020